Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
Clinical trial NCT00555399 · TERMINATED
Trial details
- NCT number
- NCT00555399
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-28
- Primary completion
- 2020-01-24
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.